People with heart disease who received a shingles vaccine had nearly half the rate of serious cardiac events within a year, according to a study of 246,822 U.S. adults presented at the American College of Cardiology's Annual Scientific Session (ACC.26). Vaccinated individuals were 46% less likely to suffer a major adverse cardiac event, 66% less likely to die from any cause, 32% less likely to have a heart attack, and 25% less likely to suffer a stroke or develop heart failure.
Researchers believe the mechanism is straightforward: shingles infections can trigger dangerous blood clots around the brain and heart, raising the risk of heart attacks, strokes, and venous thromboembolism. By preventing the infection itself, the vaccine appears to also block this clotting cascade.
The study has limitations — it only tracked outcomes during the first year after vaccination, and people who get vaccinated may tend to have healthier behaviors overall. Still, the findings add to growing evidence that common vaccines can deliver unexpected cardiovascular benefits.
